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Directed evolution was applied to identify peptide
substrates with enhanced hydrolysis rates by
MT1-MMP suitable for protease beacon develop-
ment. Screening of a random pentapeptide library,
using two-color CLiPS, yielded several substrates
identical to motifs in distinct collagens that shared
the consensus sequence P-x-GYL. To identify sub-
strates with enhanced cleavage rates, a second-
generation decapeptide library incorporating the
consensus was screened under stringent conditions,
which resulted in a MxPLGYM/LM
G/AR consensus
motif. These substrates are hydrolyzed by human-
MT1-MMP up to six times faster than reported
peptide substrates and are stable in plasma. Finally,
incubation of soluble protease beacons incorpo-
rating the optimized substrates, but not previous
substrates, enabled direct detection of endogenous
MT1-MMP activity of human-fibrosarcoma (HT-
1080) cells. Extended substrate libraries coupled
with CLiPS should be useful to generate more effec-
tive activity probes for a variety of proteolytic
enzymes.
INTRODUCTION
The extracellular degradation of collagen is an essential step
during developmental processes and in the remodeling and rapid
growth of tissues. Collagen degradation is regulated by the
expression, activation, and inhibition of several matrix metallo-
proteinases (MMPs). MMP family members including MMP-1,
2, 8, 9, 13, membrane type-1 MMP (MT1-MMP or MMP-14),
and MT2-MMP are known to hydrolyze collagens (Aimes and
Quigley, 1995; Haas et al., 1998; Knauper et al., 1997; Krane
et al., 1996; Niyibizi et al., 1994; Ohuchi et al., 1997; Patterson
et al., 2001). Although, most collagenases are secreted,
MT1-MMP is membrane-anchored and has been found to
mediate localized collagenolysis and invasive activity to both
normal and malignant cells (Sabeh et al., 2009). MT1-MMP has392 Chemistry & Biology 18, 392–401, March 25, 2011 ª2011 Elseviebeen reported to cleave several types of collagen including types
I, II, and III collagens (Ohuchi et al., 1997). Mice deficient in MT1-
MMP exhibit inadequate collagen turnover and prominent
defects that include dwarfism, arthritis, and connective tissue
disease (Holmbeck K., 1999; Kenn et al., 2004). In addition,
MT1-MMP deficient mice display loss of collagenolytic activity
in skin fibroblast cells (Holmbeck K., 1999), and similar outcomes
were observed in human fibroblasts and tumor cells when MT1-
MMP expression was silenced by interfering RNA (Holmbeck,
1999; Lee et al., 2006; Sabeh et al., 2004). These observations
support the assertion that MT1-MMP serves an important and
nonredundant role in collagenolysis during a variety of physiolog-
ical processes.
In addition to MT1-MMPs role in collagenolysis, several
studies have reported that MT1-MMP is capable of hydrolyzing
a variety of substrates including gelatin, b-casein, k-elastin, and
basement membrane or interstitial-associated proteins of the
extracellular matrix (ECM) including fibronectin, vitronectin,
laminin-1 and 5 (d’Ortho et al., 1997; Hornebeck and Maquart,
2003; Ohuchi et al., 1997; Pei and Weiss, 1996; Sato et al.,
2005). Additionally, MT1-MMP contributes to shedding of cell
adhesion molecules, such as CD44H which plays an important
role in lymphocyte activation and homing, T cell activation,
angiogenesis, and metastasis (Goodison et al., 1999; Kajita
et al., 2001; Trochon et al., 1996). Also, several biologically rele-
vant MT1-MMP substrates cleaved in cellular context were
identified by quantitative proteomics methods using isotope-
coded affinity tag labeling with tandem mass spectrometry,
such as pentraxin 3, galectin-1, proTNFa, and Hsp90a (Butler
et al., 2008; Tam et al., 2004). In addition to cleaving ECM
proteins, MT1-MMP also has been found to activate MMP
zymogens such as proMMP-2, proMMP-8 and proMMP-13
that are involved in tumor cell invasion and metastasis (Folgue-
ras et al., 2004; Holopainen et al., 2003; Itoh and Seiki, 2004;
Will et al., 1996). Elevated MT1-MMP activity has been detected
in tumor and tumor stromal cells of many tissue types but
particularly in brain, lung, gastric, and breast carcinoma tissues
(Atkinson et al., 2007; Bisson et al., 2003; Lampert et al., 1998;
Malhotra et al., 2002; Okada et al., 1995). Thus, MT1-MMP has
been demonstrated to play an essential role in cell migration,
invasion, cell morphology, metastasis, and angiogenesis in
normal physiological and pathological events (Itoh and Seiki,
2004; Seiki, 2003; Stamenkovic, 2000; Zhou et al., 2000).r Ltd All rights reserved
Figure 1. Use of FACS to Screen Peptide
Substrate Libraries (CLiPS) for MT1-MMP
Substrates
Flow cytometric analysis of cell populations repre-
senting the 5mer random library prior to screening
without MT1-MMP (A) or with MT1-MMP (B), the
final sorted populations from the 5 mer random
library without (C) or with MT1-MMP (D), and the
10 mer focused library without (E) or with (F)
MT1-MMP. See also Table S1.
Chemistry & Biology
Protease Beacons for MT1-MMP Activity MeasurementsGiven MT1-MMP’s diverse functions, inhibitors and probes
have been developed to inhibit or measure MT1-MMP activity
in vivo (Devy et al., 2009; Fujita et al., 2003). For example,
a FRET-based biosensor has been shown to enable detection
and localization of MT1-MMP activity on the membrane of
HeLa cells that are cotransfected with both the membrane-
anchored MT1-MMP probe and MT1-MMP (Ouyang et al.,
2008). However, the MT1-MMP cleavable substrate used in the
probe was hydrolyzed at a similar rate by MT2-MMP and
MT3-MMP, and the method required a high concentration of
MT1-MMP (60 nM) for cleavage. In another strategy, a MT1-
MMP-activated single photon emission computed tomography
(SPECT) imaging probewas constructed by fusing a radionuclide
to an inhibited cell penetrating peptide (CPP) to selectively target
MT1-MMP expressing cells. However, the probe was also acti-
vated in cells that do not express MT1-MMP, indicating nonspe-
cific cleavage of the MT1-MMP substrate by other MMPs
(Watkins et al., 2009). Thus the specific detection of MT1-MMP
activity in cell culture and in vivo will require substrates with
improved activity and selectivity.
The substrate specificity of MT1-MMP has been investigated
in several previous studies. Using the substrate phage display
method, the consensus substrate sequence for MT1-MMP was
found to be PxG/PL at the P3-P1
0 sites (Ohkubo et al., 1999).
Most of the substrates identified using this method were also
cleaved by MMP-2 and MMP-9. Another study using the
substrate phage methodology suggested that the specificity
for MT1-MMP can be conferred by arginine at the P4 position
and the absence of proline at the P3 position through mutational
analysis (Kridel et al., 2002). However, phage library selections
did not reveal a clear consensus for MT1-MMP selective
substrates (Kridel et al., 2002). In addition, these studies did
not characterize the activity and selectivity of other collagenases
toward the MT1-MMP substrates. Consequently, we sought
to identify MT1-MMP substrates that exhibit rapid hydrolysis
rates using two color cellular libraries of peptide substrates
(CLiPS) (Boulware and Daugherty, 2006; Boulware et al.,
2010). Using CLiPS methodology, substrates are displayed
on the surface of bacterial cells, allowing quantitative measure-
ment of the extent of substrate cleavage using flow cytometry,Chemistry & Biology 18, 392–401, March 25, 2011an advantage over substrate phage.
The use of CLiPS and substrate exten-
sion provided a highly effective directed
evolution strategy, wherein selection
stringency could be tuned using FACS.
We applied this method to identifyenhanced substrates suitable for direct MT1-MMP activity
measurements in cells.
RESULTS
Identification and Directed Evolution of MT1-MMP
Substrates Using CLiPS
To identify optimal five residue cleavage motifs for MT1-MMP,
a cellular library of peptide substrates (CLiPS) consisting of
more than 107 unique random pentamer substrates displayed
on the surface of Escherichia coli (Boulware and Daugherty,
2006) was screened using fluorescence activated cell sorting
(FACS). A two-step screening process was applied to enrich
library members that display substrates efficiently cleaved by
the catalytic domain of MT1-MMP. First, cells exhibiting green
and red (green+ red+) fluorescence were sorted after labeling
with a red fluorescent probe, streptavidin R-phycoerythin
(SA-PE), that recognizes the uncleaved N terminus and a green
fluorescent probe (AlajGFP-Mona SH3) that binds to the scaf-
fold’s C terminus irrespective of cleavage. In the second step,
library members with cleaved substrates (green+ red-) were
sorted after incubation with MT1-MMP (80 nM for 2 hr) and
labeling with red and green probes. The process was repeated
to enrich clones displaying rapidly cleaved substrates (Figure 1).
Individual identified substrates exhibited a clear preference for
proline at the P3 position, glycine at the P1 position, and
a medium-sized hydrophobic residue (L, M, I) at the P10 position;
the resulting consensus substrate sequence was P-x-G-(L/M/I).
Additionally, the P20 position exhibited a modest preference for
arginine, methionine, or leucine. The pentapeptide substrates
identified by CLiPS exhibited a high degree of identity to motifs
in known substrates including several collagen types. In fact,
themost rapidly cleaved substrate PQGLL is identical to a known
pentapeptide motif in type-1 collagen.
In an effort to identify substrates with improved hydrolysis
rates and identify residue preferences further from the scissile
bond, a secondary library of the form xxxPx(G/P)(L/M/I)xxx
was constructed. Screening the extended substrate library
under more stringent conditions (60 nM MT1-MMP for 1 hr)
enriched a population with substantially improved cleavageª2011 Elsevier Ltd All rights reserved 393
Table 1. Amino Acid Sequences and Second-Order Rate Constants for the Substrates Resulting from Sorting the 5-mer Random
Library (5-peptide), and the 10-mer Focused Library (10.peptide) for MT1-MMP
Substrate P6 P5 P4 P3 P2 P1 P10 P20 P30 P40 P50 P60 P70 kcat/KM (mM
1 Min 1)
5.1 s P Q G L L q 0.15 ± 0.01
5.2 s P Q G L R q 0.15 ± 0.02
5.3 s P M P L M A 0.12 ± 0.01
5.4 s P I G L R q 0.12 ± 0.02
5.5 s P Q G M L q 0.11 ± 0.01
5.6 s P R G M L q 0.11 ± 0.01
5.7 s P S G L R q 0.07 ± 0.01
5.8 s P R G I M q 0.06 ± 0.01
5.9 s P K G L L q 0.05 ± 0.01
5.10 s W G G L R q 0.02 ± 0.01
10.1 S L A P L G L Q R R 0.56 ± 0.02
10.2 W M K P Q G M R L M 0.54 ± 0.02
10.3 G M L P L G M R G S 0.40 ± 0.02
10.4 L Q L P S G L M G R 0.36 ± 0.04
10.5 W R A P L A L M S R 0.34 ± 0.03
10.6 G M V P V G L M A G 0.34 ± 0.04
10.7 V G E P R G M L A G S L K 0.32 ± 0.01
10.8 L R V P L G L M G K 0.32 ± 0.03
10.9 G M R P L G I A G R 0.16 ± 0.02
The second-order rate constants were determined using flow cytometry. The consensus motif from the 5-mer library was P-x-(G)-(L/M/I), and for the
10-mer focused library the consensus motif was (M/L)-x-P-L-G-(L/M)-(L/M)-(G/A)-(R/K).
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Protease Beacons for MT1-MMP Activity Measurementskinetics when compared to the primary random library (Fig-
ure 1). Lower concentrations of MT1-MMP (20 and 30 nM)
and shorter incubation times (15 and 25 min) were attempted
but did not enrich improved substrates. Individual clones
randomly selected from the final sort exhibited a consensus of
(M/L)xPLG(L/M)(
L/M)(
G/A)(
R/K) (Table 1). Lysine and arginine were
observed at the P40 position in about half of the substrates.
The substrates identified using CLiPS were searched against
the human proteome using the ScanProsite degenerate motif
search algorithm, and several of the substrate sequences
appeared in diverse ECM proteins (Table 2). Thus, screening of
a second generation library constructed using pentapeptide
consensus information yielded substrates that are hydrolyzed
more rapidly by MT1-MMP than the first generation pentapep-
tide substrates.
Characterization of Substrate Cleavage Kinetics
The cleavage rate of individual substrates were initially
measured and ranked for cell-displayed substrates (Table 1) as
previously described (Boulware and Daugherty, 2006). Sub-
strates from the 10 mer focused library exhibited up to 4-fold
enhanced hydrolysis rates on the cell surface relative to 5 mer
substrates. Soluble protease activity probes (i.e., protease
beacons) were constructed using fluorescent proteins optimized
for FRET studies as previously described (Nguyen and Daugh-
erty, 2005). Protease beaconswere constructed for three decap-
eptide substrates (C-10.1-Y, C-10.2-Y, C-10.7-Y), the most
rapidly hydrolyzed pentapeptide substrate (C-5.1-Y), and two
substrates identified using either oriented peptide libraries
(C-MPL-Y) (Turk et al., 2001) or substrate phage display394 Chemistry & Biology 18, 392–401, March 25, 2011 ª2011 Elsevie(C-A42-Y) (Kridel et al., 2002). The lowest concentration of
MT1-MMP that the FRET beacon can significantly detect was
0.3 nM (see Figure S1 available online). Extended ten-residue
substrates were cleaved 4- to 6-fold faster than the most
rapidly cleaved 5 mer PQGLL and previously reported peptide
substrates (C-A42-L, C-MPL-Y) (Figure 2A and Table 3), as
measured using fluorimetry.
Since the most rapidly cleaved substrate identified from the
random library was identical (5/5 amino acids) to a known human
type-1 collagen cleavage site PQGLL (Sato et al., 2005),
substrate hydrolysis rates were also measured for human colla-
genases MMP-1, 2, 8, 9, 13, andMT2-MMP. Although selectivity
was not explicitly favored during our screens, the most rapidly
cleaved substrate (C-10.1-Y) exhibited selectivity for MT1-
MMP over other collagenases, with the exception of MMP-9
(Table 3; Table S2). Kinetic constants (kcat/KM) measured using
FRET substrates correlated with those measured for the corre-
sponding substrate displayed on the cell surface, although the
absolute valuesmeasured using the FRET beacons were roughly
6-fold higher. The extended FRET substrate C-10.1-Y exhibited
3- to 14-fold selectivity for MT1-MMP over the other MMPs
analyzed with the exception of MMP-9.
To investigate whether the optimized substrates might be suit-
able for in vivo imaging or prodrug applications, their stability
was measured in human plasma (Figure 2B). In a 10-fold dilution
of plasma, the limit of sensitivity for the FRET assay, substrate
cleavage did not occur during a 4 hr incubation, indicating that
the MT1-MMP activity was completely inhibited by human
plasma even when diluted by 10-fold (10% plasma). The P-value
was <0.0001when theMT1-MMP activity curves of 1%and 10%r Ltd All rights reserved
AB
Figure 2. Measurement of MT1-MMP Activity Using Protease
Beacons
(A) The mean extent of conversion of the FRET substrates was measured with
respect to time after incubating with 2.5 nM MT1-MMP.
(B) The mean extent of conversion of C-10.1-Y was monitored over time after
incubating with 50 nM MT1-MMP and different concentrations of human
plasma at 37C. See also Figure S1.
Table 2. CandidateMT1-MMPSubstrates IdentifiedUsingCLiPS/
ScanProsite
Substrate
Sequence Human Protein Site
SWISS-
PROT #
PQGLL Collagen a-2 type I 863-867 P08123
Endoglin 296-300 P17813
Keratin type II 486-490 Q9NSB4
Otogelin 930-934 Q6ZR10
Agrin 1405-1409 O00468
PQGLR Collagen a-1 type VIII 233-237 P27658
Collagen a-3 type IX 419-423 Q14050
Interleukin-11 receptor a 221-225 Q14626
Interleukin-23 subunit a 79-83 Q9NPF7
Integrin b-4 103-107 P16144
LRP-6 607-611 O75581
PSGLR Fibronectin type III domain 10-14 Q9H6D8
Transforming growth factor b1 3-7 P01137
LRP-3 685-689 O75074
PKGLL Collagen a-1 type XXIV 787-791 Q17RW2
Platelet glycoprotein V 186-190 P40197
WGGLR Integrin a-5 744-748 P08648
APLGLQ Collagen a-3 type IX 497-501 Q14050
Thrombomodulin 217-221 P07204
LPSGL LPR-3 684-688 O75074
Lumican 199-204 P51884
PLGIA Collagen a 2 type I 896-900 P08123
Collagen a 1 type III 946-950 P02461
Candidate substrates have not been experimentally validated.
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cating that the hydrolysis rates are statistically significant and
MT1-MMP activity was detected only when plasma was diluted
by at least 100-fold. Thus, the FRET substrates were stable in
plasma and MT1-MMP activity was completely inhibited by
10% plasma likely due to the presence of TIMPs or other
protease inhibitors in human plasma. Finally, since imaging or
prodrug studies would benefit from cross-reactivity with mouse
MT1-MMP, substrate conversion of C-10.1-Y by mouse and
human MT1-MMP was measured and the decapeptide
substrate was cleaved at an equivalent rate when incubated
with either protease (Figure S2).
Measurement of Endogenous MT1-MMP Activity
in Human Tumor Cell Lines
Given the improved cleavage rates of the extended substrates
identified here relative to the reported MT1-MMP substrates
(C-A42-Y, C-MPL-Y), we hypothesized that endogenous MT1-
MMP activity of tumor cells could be quantified using substrate
probes exhibiting FRET. The extent of conversion of all of the
substrates did not exceed background when incubated for 4 hr
with MT1-MMP deficient breast carcinoma cells (MCF-7).
However, human fibrosarcoma cells (HT-1080) expressing
MT1-MMPmediated roughly 70% conversion in 4 hr for the opti-
mized substrates (Figure 3), while conversion of previously re-
ported substrates (C-A42-Y, C-MPL-Y) did not rise aboveChemistry & Biology 18, 320%, making activity detection difficult. Nonspecific hydrolysis
by the possible presence of soluble proteases, shed or vesicular
MT1-MMP could not be detected since serum-free conditioned
supernatants did not mediate detectable cleavage under the
same assay conditions. In addition to MT1-MMP, HT-1080 cells
have been reported to express other MMPs includingMT2-MMP
andMMP-2 (Ito et al., 2010; Sato and Takino, 2010). Importantly,
MT1-MMP was solely responsible for protease beacon activa-
tion by HT1080, since activation was completely inhibited by
a selective, high affinity anti-MT1-MMP antibody (DX-2400)
(Devy et al., 2009) (Figure S3). Again, plasma addition strongly in-
hibited substrate cleavage by cell lines, though activity was
detectable at up to 5% plasma (Figure S3). Thus, in cell-based
assays, the enhanced substrates provided at least 6-fold
increased sensitivity relative to previously reported substrates
(C-A42-Y, C-MPL-Y), enabling detection of endogenous MT1-
MMP activity.92–401, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 395
Table 3. Second-Order Rate Constants for MT1-MMP FRET Substrates
kcat/KM (mM
1 Min 1)
Substrate P6 P5 P4 P3 P2 P1 P10 P20 P30 P40 P50 P60 P70 MT1-MMP MMP-1 MMP-8a
C-10.1-Y S L A P L G L Q R R 3.9 ± 0.1 0.28 ± 0.01 0.25 ± 0.01
C-10.2-Y W M K P Q G M R L M 3.3 ± 0.2 0.21 ± 0.01 0.67 ± 0.03
C-10.7-Y V G E P R G M L A G S L K 3.3 ± 0.2 0.39 ± 0.01 0.47 ± 0.04
C-A42-Y S G R I G F L R T A 0.56 ± 0.04 0.13 ± 0.01 - - - -
C-MPL-Y I P E S L R A 0.76 ± 0.08 0.99 ± 0.01 1.41 ± 0.05
C-5.1-Y P Q G L L 1.04 ± 0.06 0.35 ± 0.01 1.15 ± 0.06
a Active site titration was not performed for MMP-8.
Standard deviation values are derived from triplicate measurements. See also Table S2.
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Matrix metalloproteinases exhibit similar active site structures
that can account for the high similarity of short peptide
substrates for different MMP family members and the difficulty
in designing small molecule inhibitors that are selective for
particular MMPs (Hooper, 1994; Stocker et al., 1995). For
instance, several MMPs recognize peptide substrates that
contain the P-x-x-F motif (where F is a hydrophobic amino
acid) similar to those found in gelatins and collagens (Chen
et al., 2002; Deng et al., 2000; Kridel et al., 2001). The extended
substrates identified here, exhibited significantly increased rates
of hydrolysis by MT1-MMP when compared to shorter
substrates. In previous studies that involved screening of
random peptide libraries for MT1-MMP substrates, substrates
with the highest cleavage rates exhibited poor selectivity and
were cleaved at similar or greater rates by nontarget proteases
(Kridel et al., 2002; Ohkubo et al., 1999). However, activity
enhancement via substrate extension yielded substrates that
were preferentially cleaved by MT1-MMP when compared to396 Chemistry & Biology 18, 392–401, March 25, 2011 ª2011 Elsevieseveral closely related MMP family members. Even so, our
results indicate that substrate extension provides a straightfor-
ward approach to increase substrate contacts with the protease
surface neighboring the catalytic cleft to improve substrate
recognition and hydrolysis rates.
Quantitative activity-based substrate library screening
combined with bioinformatic analysis identified a group of
candidate physiological substrates localized in the ECM and
on cell surfaces. In vitro methods for protease specificity char-
acterization, although useful for active site specificity analysis,
are often insufficient to unambiguously identify physiological
substrates. For example, solution phase positional scanning
or oriented peptide libraries can quickly reveal the full spectrum
of subsite preferences, but do not identify cooperative effects
nor individual preferred substrates that implicate physiological
substrates (Schneider and Craik, 2009; Turk et al., 2001).
Substrate phage (Deperthes, 2002) and CLiPS methods (Boul-
ware and Daugherty, 2006) can implicate physiological
substrates, primarily for relatively specific enzymes that cleave
a smaller number of substrates. Here, screening for rapidFigure 3. Measurement of MT1-MMP
Activity in Tumor Cells Using Protease
Beacons
MT1-MMP FRET beacons were incubated with
MCF-7 and HT1080 cells or conditioned media
and substrate conversion was monitored over
time at 37C. See also Figures S2 and S3.
r Ltd All rights reserved
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motifs in several human collagens, including types (I, III, VIII,
IX, etc.). Use of ScanProSite revealed that PQGLR is identical
to a known substrate within human type IX collagen (a3) and
type VIII collagen (a1). Substrates PQGLL and PIGLR occur in
type I collagen (a2) and type XI collagen (a1), respectively
(Sato et al., 2005). Furthermore, PMPLMA is similar to the
sequence PSPII, a cleavage site for proMMP-2 activation
(Ohkubo et al., 1999). In addition to collagens, the optimal
pentapeptide PQGLL substrate motif occurs 51 times in the
human genome and conspicuously occurs in a variety of ECM
proteins including keratin type II, agrin (a laminin-associated
protein of the basal lamina (Remacle et al., 2006)), and endoglin
(a major endothelial cell glycoprotein involved in cell migration
(Garcia-Pozo et al., 2008)). Moreover, the extended consensus
motif PxGLxxR is present in multiple integrins, disintegrin, and
metalloprotease (ADAM) family proteases whose cleavage
could activate an invasive program in cascade fashion. Thus,
extended substrate consensus data suggested an array of
candidate physiological substrates present within the ECM.
Even so, our results suggest that collagenolysis is a primary
function of MT1-MMP.
CLiPS provided a highly effective tool for substrate discovery
and optimization, owing to quantitative library analysis and
screening using FACS. Substrate phage, proteome-derived
database-searchable peptide libraries, positional scanning
combinatorial libraries and CLiPS have been applied to identify
substrates but typically have not been used for directed evolu-
tion (Boulware and Daugherty, 2006; Deperthes, 2002; Harris
et al., 2000; Schilling and Overall, 2008). CLiPS has been shown
to enable substrate identification for both promiscuous and
highly specific proteases including caspase-3, enteropeptidase
(Boulware and Daugherty, 2006), staphylopains A and B from
Staphylococcus aureas (Dubin et al., 2008; Stec-Niemczyk
et al., 2009), karolysin, an MMP-like protease from a periodontal
pathogen (Karim et al., 2010), and here, MT1-MMP. CLiPS has
also enabled directed evolution of substrate activity for the
tobacco etch virus TEV nuclear inclusion protease, which identi-
fied substrates with high sequence similarity to the native TEV
substrate (Boulware et al., 2010). ForMT1-MMP, flow cytometric
population analysis enabled efficient identification of the
concentration and reaction time that would yield only the most
rapidly cleaved substrates. Although not favored explicitly during
screening, selectivity could be further evolved by counter
screening to remove substrates that are cleaved by other
proteases.
Detecting and measuring the activity of proteases including
MMPs in vivo and in ex vivo tissues remains a challenge. Proteo-
lytic activity is usually detected using gelatin or collagen zymog-
raphy, in situ zymography or protease beacons (Snoek-van
Beurden and Von den Hoff, 2005). However, protease activity
probes frequently suffer from insufficient selectivity and activity,
and can be expensive to synthesize. Zymography methods do
not generally identify the protease species hydrolyzing the
substrate, since they report the activity of a variety of proteases
that can degrade gelatin or collagen including many MMPs,
cathepsins, and stratum corneum thiol protease (Hashimoto
et al., 2006; Platt et al., 2006; Watkinson, 1999). Furthermore,
reliable identification of the active MMP species in zymogramsChemistry & Biology 18, 3can be difficult due to the fact that MMPs can form complexes
(Snoek-van Beurden and Von den Hoff, 2005). In an attempt to
address this limitation, several protease imaging probes or
protease beacons have been designed to detect individual
protease activities in vitro and in vivo (Chen et al., 2009; Jiang
et al., 2004; Law and Tung, 2009; Wunder et al., 2004). However,
frequently utilized chromogenic and fluorogenic substrate
probes lack prime side amino acids that influence activity and
selectivity. The FRET beacons developed here using FRET-opti-
mized fluorescent proteins yielded a large dynamic range
(20-fold) to enable highly sensitive MT1-MMP detection. Thus,
the present study demonstrates that extended substrate
peptides can provide critical gain of function for the detection,
localization, and quantification of activity of specific proteases
in vitro, providing a new tool for basic and applied studies of
proteolytic enzymes.
SIGNIFICANCE
Given the diverse roles of MT1-MMP in normal physiological
and pathological events, especially in cell invasion, metas-
tasis, and angiogenesis, several imaging probes have been
designed to report MT1-MMP activity. However, the utility
of these probes is limited by their low sensitivity and selec-
tivity for MT1-MMP. Here, improved MT1-MMP substrates
were developed using CLiPS to iteratively evolve activity.
The best substrates identified exhibited substantially
greater hydrolysis rates than previously identified peptide
substrates, and preferential cleavage by MT1-MMP over
several other family members. These extended substrates,
when incorporated into FRET beacons, enabled direct
detection of endogenous MT1-MMP activity in tumor cell
lines. Thus, the present substrate discovery approach
should have utility for developing improved protease-
activity probes for a variety of in vivo and ex vivo
applications.
EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
Human fibrosarcoma (HT1080) and breast carcinoma (MCF-7) cell lines were
obtained from American Type Culture Collection (ATCC). Tumor cells were
cultured in Minimum Essential Medium (Eagle) or RPMI-1640 from ATCC sup-
plemented with 10% fetal bovine serum, 100 units/ml penicillin, and 50 mg/ml
streptomycin (Invitrogen, Carlsbad, Ca). Bacterial experiments were per-
formed with E. coli strain MC1060 and grown in LB medium supplemented
with 34 ug/ml chloramphenicol. Soluble catalytic domains of matrix metallo-
proteinases: MMP-1, MMP-2, MMP-8, MMP-9, MMP-13, and MT1-MMP
were obtained from BIOMOL International LP (Plymouth Meeting, PA). MT2-
MMP was obtained from Chemicon (Ca). Ni-NTA resin was purchased
from QIAGEN. Streptavidin-R-phycoerythrin (SAPE) was from Invitrogen.
BPER-II Bacterial Protein Extraction Reagent was from Pierce (Rockford, IL).
Oligonucleotides were from Operon Biotechnologies (Huntsville, AL) and
restriction enzymes were from New England Biolabs (Ipswich, MA). Human
(ID 6046773) and Murine (ID 30658833) MT1-MMP cDNA were purchased
from Open Biosystems. DX-2400 anti-MT1-MMP antibody was provided as
a generous gift from Dyax (Cambridge, MA). Galardin GM-6001 was
purchased from Enzo life Sciences (Plymouth Meeting, PA).
Construction of Substrate and Plasmids
The two color CLiPS 5 mer random library (pBSGXP2) previously described
(Boulware et al., 2010) was used to enrich for cleavable peptides for92–401, March 25, 2011 ª2011 Elsevier Ltd All rights reserved 397
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Protease Beacons for MT1-MMP Activity MeasurementsMT1-MMP. Plasmid (pBSGXP2-2) was constructed with a streptavidin-
binding peptide (WVCHPMWEVMCLR) (Rice et al., 2006), and linker
(GGSGQSGLGSGSGSGSGQSG) on the N terminus of CPX, and binding
peptide of SLP-76 (PAPSIDRSTKPPL, P2) on the C terminus. Plasmid
pBSGXP2-2 was constructed by using the pBSGXP2 (Boulware et al., 2010)
as a template and was amplified with primers 1 and 2 (Table S1) to remove
the SfiI site upstream of the SA-PE binding peptide. The PCR fragment was
then amplified with primers 3 and 4 to append a SfiI site downstream of the
SA-PE binding peptide. Similarly, a 10 mer focused library of the form x-x-x-
P-x-(G/P)-(L/M/I)-x-x-x was constructed with the pBSGXP2 as a template
for PCR with primers 5 and 6. The PCR product was digested with SfiI, ligated
into similarly digested pBSGXP2-2, and transformed into electro-competent
E. coli yielding 8 3 107 independent transformants.
The CyPet-YPet caspase substrate plasmid (pBCcpY) was used as
a template plasmid to construct the MT1-MMP cleavable FRET substrates
(Nguyen and Daugherty, 2005). The CyPet gene in pBCcpY was replaced
with another having optimized codons for E. coli expression (Codon Devices).
FRET substrates were constructed to encode the MT1-MMP substrates by
amplifying YPet using the new plasmid template with forward primer 7 (all
substrates except the 10.7) and 8 (for 10.7) to add a GGSQSAG linker on the
N terminus of YPet, and reverse primer 9. The PCR fragment was amplified
with reverse primer 1 and forward primers 10, 11, 12, 13, 14, and 15, to encode
the substrates represented in 10.1, 10.2, 10.7, 5.1, a substrate reported in
(Kridel et al., 2002), and a substrate reported in Turk (Turk et al., 2001), respec-
tively. The PCR fragments were then digested with KpnI and SphI and ligated
with the similarly digested plasmid (pBCcpY-2) to yield the plasmid C-10.1-Y,
C-10.2-Y, C-10.7-Y, C-5.1-Y, C-A42-Y, and C-MPL-Y.
Genes encoding the catalytic domains of mouse and human MT1-MMP (aa
Y112-R299) were amplified with forward primers 16 and 17 and reverse
primers 18 and 19, respectively, to append a SfiI restriction site upstream of
the C-terminal hexa-histidine tag. The resulting PCR products were amplified
with forward primers 16 and 17 and reverse primer 20 to add a SfiI restriction
site at the C terminus. The PCR fragments were digested with SfiI and ligated
into a similarly digested plasmid (pBCcpY-2).
Identification of Peptide Substrates for MT1-MMP Using CLiPS
To screen the 5mer random library, the overnight bacterial culture was subcul-
tured 1:50 for 2 hr at 37Cand then inducedwith 0.1% (w/v) L-(+)-arabinose for
3 hr at room temperature. Approximately 108 cells were washed with reaction
buffer, and then pelleted. The reaction buffer was 50 mM Tris-Cl (pH 7.5) sup-
plemented with 20 mMNaCl, 2mM CaCl2, and 10 mMZnCl2. The pelleted cells
were then resuspended in 20 ml of reaction buffer and the volume was then
divided in half. The first sample was incubated with 80 nM MT1-MMP and
the second sample was incubated in the absence of enzyme, and both reac-
tion samples were incubated at room temperature with shaking for 2 hr. The
samples were then diluted 1:100 in phosphate buffered saline (PBS pH 7.4)
to impede the reaction, then resuspended in PBS supplemented with 50 nM
SA-PE and 250 nM AlajGFP-Mona SH3 to label the cells and were incubated
at 4C for 1 hr. The labeled cells were then washed with PBS and analyzed on
a FACSAria (BD Biosciences) with 488 nm excitation and fluorescence at 530
and 576 nm was measured. A total of eight sorts were performed, alternating
between isolating for cells that properly display substrates while excluding
potential AlajGFP-Mona SH3 ligands in the absence of MT1-MMP (green+
red+) and then sorting cells with cleaved substrates after incubating with
MT1-MMP (green+ red–). Cells from the final round of sorting were plated to
isolate single clones for DNA sequencing. The 10 mer focused library was
screened similarly, with the exception that the cells were incubated with
MT1-MMP (60 nM) at room temperature for 1 hr with shaking, and after labeling
the cells. A total of seven sorts were performed; four for cleavage and three for
display, while alternating between sorting for display and for cleavage.
Characterization of the Activity of Cell Displayed Substrates
Tomeasure the extent of conversion of cell displayed substrates, the overnight
bacterial cultures of the clones from the final sort of the 5 mer random library
were subcultured as before in duplicate samples, and substrate display was
induced for 3.5 hr at room temperature. Cells were washed and resuspended
in reaction buffer (10 ml) and the volume was then divided in half (each 5 ml), the
first sample was incubated with 80 nMMT1-MMP and the second sample was398 Chemistry & Biology 18, 392–401, March 25, 2011 ª2011 Elsevieincubated without enzyme (10 ml final reaction volume), and both reaction
samples were incubated at room temperature with shaking for 45 and
75 min. Cells were washed and labeled with 50 nM SA-PE. The labeled cells
were again washed in PBS and their fluorescence was measured by flow
cytometry. Conversions for 10 mer substrates were similarly measured in
duplicate after 20 and 40 min incubations at room temperature. Conversion
was calculated using the expression:
conversion=
FR  FR+
FR  F0 ; (1)
where FR is the red fluorescence after incubation without the enzyme, FR+ is
the red fluorescence after incubation with the enzyme, and F0 is the fluores-
cence of unlabeled cells. It has been reported that the KM of MT1-MMP for
a short peptide substrate is 10 mM (Toth et al., 2002). The Michaelis-Menton
equation can then be simplified into a linear first order equation since the
concentration of substrates expressed on the surface of the cells ([S]) is
approximately 0.08 mM and KM > > [S]. Thus, the second-order rate constant
can be expressed as
kcat
KM
=  Ln½ð1 ConversionÞ½E,t ; (2)
where [E] is the enzyme concentration, and t is the time at which the conversion
measurement was taken (Boulware and Daugherty, 2006). The reported
kcat/KM values are averages at the two different time points.
Measurement of MT1-MMP Activity Using Protease Beacons
The concentrations of active MMP-1, MMP-2, MMP-9, MMP-13, MT1-MMP,
andMT2-MMPwere determined by active site titration withMMP tight inhibitor
Galardin. To determine the second-order rates constants of the substrates in
soluble form, bacterial cultures expressing the C-terminal hexa-histidine
tagged protease beacons were subcultured 1:100 in 40 ml volume for 2 hr at
37C, and then induced with 0.2% (w/v) L-(+)-Arabinose for 18 hr at room
temperature. Expressed protein was extracted from cells using B-PER II
reagent and was further purified using affinity chromatography by using Ni-
NTA and following the suggested protocol. The concentration of the protein
was measured by using a standard curve of fluorescence intensity at
527 nm as a function of YPet concentration when excited with 514 nm. The
hydrolysis reaction for each peptide was performed in triplicate in 100 ml total
volume using the same reaction buffer with 120 nM FRET substrate. To
monitor the cleavage of the peptides, the fluorescence emission at 485 and
527 nm was measured every 5 min upon excitation with 433 nm using a Tecan
Safire fluorescence spectrophotometer (Tecan, Durham, NC). To determine
the minimum concentration of MT1-MMP needed for hydrolysis detection,
C-10.1-Y substrate was incubated with different concentrations of MT1-
MMP (25 nM, 8 nM, 2.5 nM, 0.92 nM, and 0.3 nM) were incubated with
C-10.1-Y at 37C for 4 hr. The substrates were also treated with 8 nM
MMP-1, 8 nM MMP-8, and 2.5 nM MT1-MMP at room temperature for 4 hr
to analyze substrate selectivity. In a separate assay, the FRET substrates
were also treated with 2.2 nM MMP-2, 3.9 nM MMP-9, 2.3 nM MMP-13,
3.2 nMMT2-MMP, and 1.5 nMMT1-MMP at 37C for 4 hr to analyze substrate
selectivity. The second-order rate constants (kcat/KM) were then calculated by
fitting the substrate conversion to the simplified Michaelis-Menton equation
(Equation 2). The extent of conversion of the FRET substrates at different
time points was determined using the following equation:
Conversion=
FRi  FRt
FRi  FRmin; (3)
where FRi is the initial FRET ratio (527:485 nm), FRmin is the minimum FRET
ratio, and FRt is the FRET ratio at a particular time point after subtracting the
background fluorescence. The second-order rate constant (kcat/KM) was
determined by fitting to Equation 2. To determine whether endopeptidases
present in heparinized human plasma could hydrolyze the FRET substrates,
individual substrates (120 nM) were incubated in 10% plasma in 100 ml total
volume using the same reaction buffer at 37C for 4 hr. To determine if human
plasma influences the activity of MT1-MMP, C-10.1-Y was incubated with
10%, 1%, and 0% plasma with 50 nM MT1-MMP in 100 ml reaction volume
using same reaction buffer at 37C for 4 hr. The hydrolysis of the substrates
was monitored by measuring the emission fluorescence at 485 and 527 nmr Ltd All rights reserved
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peptide substrates were cross-reactive with murine MT1-MMP, both mMT1-
MMP and hMT1-MMP catalytic domains were expressed recombinantly in
E. coli then extracted from cells using B-PER II reagent and purified using
Ni-NTA. The expressed proteases were then incubated with 1 nM hMT1-
MMP (Biomol) for 1 hr at 4C and 30min at 37C to auto-activate the proteases
(Koo et al., 2002). Then 120 nM of C-10.1-Y was incubated with 10 mM of the
expressed MT1-MMP. The FRET substrate was also incubated with the reac-
tion buffer and 1nM MT1-MMP to verify that hydrolysis was not a result of the
added protease. Substrate conversion was monitored by measuring the fluo-
rescence emission at 485 and 527 nm.
Measurement of MT1-MMP Activity in Tumor Cell Lines Using
Protease Beacons
To measure tumor cell-associated substrate cleavage, HT-1080 or MCF-7
cells were washed with reaction buffer and cultured in RPMI-1640 (without
FBS or phenyl-red indicator) for 18 hr. Cells were then scraped and pelleted.
The medium was collected and the cells were washed twice with 5 ml of reac-
tion buffer. The FRET substrates at 120 nM final concentration were then incu-
bated with the tumor cells in 100 ml reaction volume using the same reaction
buffer at 37C for 4 hr in duplicate. In another assay, the substrates were incu-
bated with tumor cell conditioned media in duplicate to determine if any
soluble protease can cleave the substrates. To determine whether hydrolysis
is due to MT1-MMP and not other MMPs, HT-1080 cells were incubated with
a highly selective anti-MT1-MMP antibody antagonist at 90 nM DX-2400 for
1 hr at 4C. The cells were then incubated with 120 nM of C-10.1-Y at 37C
in 100 ml reaction volume. To determine if plasma can inhibit proteases
produced by the tumor cells, the FRET substrate C-10.1-Y was incubated
with HT-1080 cells with the following dilutions of human plasma in duplicate:
0%, 1%, 5%, and 20%, and hydrolysis was monitored as described above.
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